Equasens Société anonyme (0R9T.L)
EUR 44.15
(1.03%)
EUR 44.15
(1.03%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 10.31 Million EUR | 10.77% |
| 2022 | 9.31 Million EUR | 4.92% |
| 2021 | 8.87 Million EUR | 30.94% |
| 2020 | 6.77 Million EUR | 52.6% |
| 2019 | 4.44 Million EUR | -13.06% |
| 2018 | 5.1 Million EUR | 83.67% |
| 2017 | 2.78 Million EUR | 8.21% |
| 2016 | 2.57 Million EUR | 7.8% |
| 2015 | 2.38 Million EUR | 3.65% |
| 2014 | 2.3 Million EUR | 20.67% |
| 2013 | 1.9 Million EUR | -4.32% |
| 2012 | 1.99 Million EUR | -5.41% |
| 2011 | 2.1 Million EUR | 4.31% |
| 2010 | 2.01 Million EUR | -6.44% |
| 2009 | 2.15 Million EUR | 64.86% |
| 2008 | 1.3 Million EUR | -13.02% |
| 2007 | 1.5 Million EUR | -14.39% |
| 2006 | 1.75 Million EUR | -28.45% |
| 2005 | 2.45 Million EUR | -0.89% |
| 2004 | 2.47 Million EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 10.98 Million EUR | 0.0% |
| 2024 Q1 | 10.98 Million EUR | 6.48% |
| 2023 Q3 | 10.31 Million EUR | 21.41% |
| 2023 FY | 10.31 Million EUR | 10.77% |
| 2023 Q4 | 10.31 Million EUR | 0.0% |
| 2023 Q1 | 8.49 Million EUR | -8.76% |
| 2023 Q2 | 8.49 Million EUR | 0.0% |
| 2022 FY | 9.31 Million EUR | 4.92% |
| 2022 Q4 | 9.31 Million EUR | 0.0% |
| 2022 Q3 | 9.31 Million EUR | -25.36% |
| 2022 Q2 | 12.47 Million EUR | 0.0% |
| 2022 Q1 | 12.47 Million EUR | 40.57% |
| 2021 Q3 | 8.87 Million EUR | 12.46% |
| 2021 Q1 | 7.89 Million EUR | 16.44% |
| 2021 Q2 | 7.89 Million EUR | 0.0% |
| 2021 Q4 | 8.87 Million EUR | 0.0% |
| 2021 FY | 8.87 Million EUR | 30.94% |
| 2020 Q4 | 6.77 Million EUR | 0.0% |
| 2020 FY | 6.77 Million EUR | 52.6% |
| 2020 Q2 | 7.67 Million EUR | 0.0% |
| 2020 Q1 | 7.67 Million EUR | 72.91% |
| 2020 Q3 | 6.77 Million EUR | -11.75% |
| 2019 Q3 | 4.44 Million EUR | -11.23% |
| 2019 FY | 4.44 Million EUR | -13.06% |
| 2019 Q4 | 4.44 Million EUR | 0.0% |
| 2019 Q2 | 5 Million EUR | 0.0% |
| 2019 Q1 | 5 Million EUR | -2.06% |
| 2018 Q3 | 5.1 Million EUR | 48.53% |
| 2018 FY | 5.1 Million EUR | 83.67% |
| 2018 Q2 | 3.43 Million EUR | 0.0% |
| 2018 Q4 | 5.1 Million EUR | 0.0% |
| 2018 Q1 | 3.43 Million EUR | 23.66% |
| 2017 FY | 2.78 Million EUR | 8.21% |
| 2017 Q4 | 2.78 Million EUR | 0.0% |
| 2017 Q3 | 2.78 Million EUR | -1.87% |
| 2017 Q2 | 2.83 Million EUR | 0.0% |
| 2017 Q1 | 2.83 Million EUR | 10.27% |
| 2016 Q4 | 2.57 Million EUR | 0.0% |
| 2016 FY | 2.57 Million EUR | 7.8% |
| 2016 Q1 | 2.77 Million EUR | 16.53% |
| 2016 Q2 | 2.77 Million EUR | 0.0% |
| 2016 Q3 | 2.57 Million EUR | -7.49% |
| 2015 Q1 | 2.26 Million EUR | -1.61% |
| 2015 FY | 2.38 Million EUR | 3.65% |
| 2015 Q2 | 2.26 Million EUR | 0.0% |
| 2015 Q3 | 2.38 Million EUR | 5.35% |
| 2015 Q4 | 2.38 Million EUR | 0.0% |
| 2014 Q3 | 2.3 Million EUR | 16.1% |
| 2014 Q1 | 1.98 Million EUR | 3.93% |
| 2014 Q2 | 1.98 Million EUR | 0.0% |
| 2014 FY | 2.3 Million EUR | 20.67% |
| 2014 Q4 | 2.3 Million EUR | 0.0% |
| 2013 Q2 | 1.83 Million EUR | 0.0% |
| 2013 Q4 | 1.9 Million EUR | 0.0% |
| 2013 Q3 | 1.9 Million EUR | 3.98% |
| 2013 FY | 1.9 Million EUR | -4.32% |
| 2013 Q1 | 1.83 Million EUR | -7.98% |
| 2012 Q4 | 1.99 Million EUR | 0.0% |
| 2012 Q2 | 1.75 Million EUR | 0.0% |
| 2012 FY | 1.99 Million EUR | -5.41% |
| 2011 Q2 | 1.93 Million EUR | 0.0% |
| 2011 Q4 | 2.1 Million EUR | 0.0% |
| 2011 FY | 2.1 Million EUR | 4.31% |
| 2010 Q2 | 1.44 Million EUR | 0.0% |
| 2010 FY | 2.01 Million EUR | -6.44% |
| 2010 Q4 | 2.01 Million EUR | 0.0% |
| 2009 FY | 2.15 Million EUR | 64.86% |
| 2009 Q4 | 2.15 Million EUR | 0.0% |
| 2008 FY | 1.3 Million EUR | -13.02% |
| 2007 FY | 1.5 Million EUR | -14.39% |
| 2006 FY | 1.75 Million EUR | -28.45% |
| 2005 FY | 2.45 Million EUR | -0.89% |
| 2004 FY | 2.47 Million EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Cegedim SA | 9.2 Million EUR | -12.097% |
| Guerbet SA | 305.17 Million EUR | 96.62% |
| Nexus AG | 3.22 Million EUR | -219.616% |
| Bastide Le Confort Médical SA | 43.2 Million EUR | 76.129% |
| Revenio Group Oyj | 10.5 Million EUR | 1.771% |
| Drägerwerk AG & Co. KGaA | 657.88 Million EUR | 98.432% |
| Sartorius Aktiengesellschaft | 1.03 Billion EUR | 99.005% |
| LNA Santé SA | 148.29 Million EUR | 93.045% |
| Siemens Healthineers AG | 4.26 Billion EUR | 99.758% |
| Medios AG | 60.43 Million EUR | 82.934% |
| Stratec SE | 142.62 Million EUR | 92.768% |